11C-美托咪酯PET/CT检出先天性肾上腺增生女性多发异位肾上腺残余肿瘤
一例32岁21-羟化酶缺陷症所致失盐型先天性肾上腺增生女性,因双侧肾上腺髓脂肪瘤先后切除,术后睾酮和ACTH显著升高,CT未见肾上腺实质。18FDG-PET/CT示卵巢/卵巢旁高代谢,11C-美托咪酯PET/CT进一步定位卵巢/附件、脾后及右膈脚与下腔静脉间摄取,提示肾上腺残余肿瘤。
要点
- 先天性肾上腺增生女性即使接受超生理剂量糖皮质激素抑制,异位肾上腺残余肿瘤仍可导致雄激素控制困难。
- 11C-美托咪酯PET/CT可敏感显示肾上腺残余肿瘤,本例为首例报道。
- 双侧肾上腺切除后CT无肾上腺实质显现时,需考虑异位肾上腺残余肿瘤。
核心结论
- 肾上腺残余肿瘤可在超生理剂量糖皮质激素抑制下导致高安德鲁水平。
- 本例首次展示11C-美托咪酯PET作为敏感方法记录肾上腺残余肿瘤的价值,该情况目前被认为在先天性肾上腺增生女性中罕见。
研究设计与样本
- 病例报告:一例32岁女性,因21-羟化酶缺陷症所致失盐型先天性肾上腺增生,行右侧肾上腺切除(因大髓脂肪瘤),后于39岁切除左侧肾上腺(因增大的髓脂肪瘤)。
- 术后一月血清睾酮从术前4.1升至18.3 nmol/L(参考0.2-1.8 nmol/L),ACTH从32升至283 pmol/L(参考<14 pmol/L),CT未见肾上腺实质。
主要发现
- 18FDG-PET/CT联合促肾上腺皮质激素刺激显示卵巢/卵巢旁高代谢,提示肾上腺残余肿瘤。
- 11C-美托咪酯PET/CT显示摄取定位于卵巢/附件、脾后及右膈脚与下腔静脉之间。
临床怎么用
- 对于先天性肾上腺增生女性,若超生理剂量糖皮质激素抑制下雄激素仍难以控制,应怀疑异位肾上腺残余肿瘤。
- 11C-美托咪酯PET/CT可作为定位肾上腺残余肿瘤的敏感影像学方法。
局限性
- 为单例病例报告,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Women with congenital adrenal hyperplasia (CAH) may present with androgen excess that is difficult to control with conventional suppressive doses of glucocorticoids. Clinical management is challenging, and the woman is at great risk of developing steroid-induced complications. PATIENTS AND METHODS: A 32-year-old woman with salt-wasting CAH due to 21-hydroxylase deficiency underwent right-sided adrenalectomy because of a large myelolipoma. Over the years, androgens became increasingly difficult to suppress on prednisolone 5 + 0 + 2.5 mg daily, and at age 39 years the left adrenal with an enlarging myelolipoma was removed. A month later serum testosterone levels had increased from 4.1 preoperatively to 18.3 nmol/L (reference 0.2-1.8 nmol/L), and adrenocorticotropin levels from 32 to 283 pmol/L (reference < 14 pmol/L). No adrenal parenchyma was visualized on computed tomography (CT). In the further search for the source of the markedly elevated testosterone, positron emission tomography (PET) was performed with 2 different tracers, 18fluorodeoxyglucose (18FDG) reflecting glucose metabolism and 11C-metomidate, an inhibitor of 11-β-hydroxylase targeting adrenocortical tissue. RESULTS: 18FDG-PET/CT with cosyntropin stimulation showed ovarian/paraovarian hypermetabolism, suggestive of adrenal rest tumors. Further characterization with 11C-metomidate PET/CT showed uptakes localized to the ovaries/adnexa, behind the spleen, and between the right crus diaphragmaticus and inferior vena cava. CONCLUSION: Adrenal rest tumors can give rise to high androgen levels in spite of suppressive supraphysiological glucocorticoid doses. This case illustrates, for the first time, the value of 11C-metomidate PET as a sensitive method in documenting adrenal rest tumors, currently considered rare in women with CAH.
引用
- Burman P, Falhammar H, Waldenström E, et al. 11C-Metomidate PET/CT Detected Multiple Ectopic Adrenal Rest Tumors in a Woman With Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab. 2021. PMID: 33245336. doi:10.1210/clinem/dgaa870
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。